All News #Library
Biotech
Cellectis` Cema-Cel Shows Strength In Pivotal Trial Interim Data
13 Apr 2026 //
GLOBENEWSWIRE
IDEAYA Biosciences, Servier Report Positive Phase 2/3 Trial
13 Apr 2026 //
PR NEWSWIRE
IDEAYA, Servier Advance Top Eye Cancer Drug to FDA
13 Apr 2026 //
BIOSPACE
IDEAYA and Servier`s Eye Cancer Drug Meets Trial Goal
13 Apr 2026 //
REUTERS
IDEAYA Biosciences To Release Phase 2/3 Optimum-02 Trial Results
11 Apr 2026 //
PR NEWSWIRE
kyron.bio Announces Strategic Partnership with Servier
09 Mar 2026 //
GLOBENEWSWIRE
Servier Bolsters Brain Cancer Portfolio in $2.5B Day One Deal
07 Mar 2026 //
BIOSPACE
Oncodesign Gets MJFF Support for LRRK2 Parkinson’s Drug
03 Mar 2026 //
PHARMIWEB
SC Clears Zydus to Sell Cancer Drug; BMS Told to Map Patents
11 Feb 2026 //
ECONOMICTIMES
Insilico Medicine, Servier Partner For $888M Oncology Drug
04 Jan 2026 //
PR NEWSWIRE
Servier India Initiates Biomarker Testing For AML
11 Nov 2025 //
EXPRESSPHARMA
Servier Showcases Leadership In IDH-Mutant Glioma At SNO 2025
10 Nov 2025 //
PR NEWSWIRE
Servier Showcases Hematology Research Commitment at ASH 2025
06 Nov 2025 //
PR NEWSWIRE
Servier Reports Extended Efficacy of Voranigo in INDIGO Trial
03 Nov 2025 //
PR NEWSWIRE
Servier Receives Positive CHMP Opinion for Voranigo
25 Jul 2025 //
PR NEWSWIRE
BioMed X & Servier Start AI Antibody Lab In Paris-Saclay
09 Jul 2025 //
INDPHARMAPOST
Servier & Black Diamond Ink Global Licensing Deal For BDTX-4933
19 Mar 2025 //
GLOBENEWSWIRE
Servier Data at ASH 2023 Furthers Leadership in Hematologic Malignancies
05 Dec 2023 //
PR NEWSWIRE
Taiho Oncology & Servier Announce in New Engl& Journal pH 3 Data for (LONSURF®)
03 May 2023 //
BUSINESSWIRE
Servier & Taiho Present Survival Data for LONSURF With Bevacizumab at 2023 ASCO
17 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support